Active Von Hippel Lindau Tumor Suppressor (vHL)
HRCA1; RCA1; VHL1; Von Hippel-Lindau Syndrome
- Product No.UAPJ769Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- TraitsFreeze-dried powder
- Purity> 80%
- Isoelectric Point4.4
- ApplicationsCell culture; Activity Assays.
- Download n/a
- UOM 10µg50µg 200µg 1mg 5mg
-
FOB
US$ 143
For more details, please contact local distributors!US$ 358
For more details, please contact local distributors! US$ 715
For more details, please contact local distributors! US$ 2145
For more details, please contact local distributors! US$ 5363
For more details, please contact local distributors!
ACTIVITY TEST of the Active Von Hippel Lindau Tumor Suppressor (vHL)
Von Hippel Lindau Tumor Suppressor (vHL) is a key tumor suppressor that plays a critical role in regulating cellular responses to oxygen levels. Encoded by the VHL gene, this protein functions primarily as part of a multi-protein E3 ubiquitin ligase complex, which targets specific proteins for degradation via the ubiquitin-proteasome system. To test the effect of vHL on cell proliferation, 293T cells were seeded into triplicate wells of 96-well plates and allowed to attach, replaced with various concentrations of recombinant human vHL. After incubated for 72h, cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10 µl of CCK-8 solution was added to each well of the plate, then the absorbance at 450 nm was measured using a microplate reader after incubating the plate for 1-4 hours at 37 ℃. Cell viability was assessed by CCK-8 assay after incubation with recombinant human vHL for 72h. The result was shown in Figure 1. It was obvious that vHL significantly decreased cell viability of 293T cells. The ED50 of recombinant human vHL is 1.607 μg/ml.
USAGE of the Active Von Hippel Lindau Tumor Suppressor (vHL)
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE of the Active Von Hippel Lindau Tumor Suppressor (vHL)
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY of the Active Von Hippel Lindau Tumor Suppressor (vHL)
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
INCREMENT SERVICES
BCA Protein Quantification Kit
Molecular Mass Marker for Protein
Monoclonal Antibody Customized Service
Polyclonal Antibody Customized Service
Protein Activity Test Experiment Service
Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
Buffer
Lentivirus Packaging Experiment Service
Adenovirus Packaging Experiment Service
Real Time PCR Experimental Service
Spike RBD Protein (S-RBD)
Protein G
Protein A
Related products
| Catalog No. | Organism species: Homo sapiens (Human) | Applications (RESEARCH USE ONLY!) |
| UAPJ769Hu01 | Active Von Hippel Lindau Tumor Suppressor (vHL) | Cell culture; Activity Assays. |
| URPJ769Hu01 | Recombinant Von Hippel Lindau Tumor Suppressor (vHL) | Positive Control; Immunogen; SDS-PAGE; WB. |
